IP Library Granted Patent US 7,537,886
Granted Patent B1
US 7,537,886 · App. 09/599,594 · Granted May 26, 2009

Primers and methods for the detection and discrimination of nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,537,886
App. No.
09/599,594
Granted
May 26, 2009
Kind
B1
Abstract

The present invention provides novel primers and methods for the detection of specific nucleic acid sequences. The primers and methods of the invention are useful in a wide variety of molecular biology applications and are particularly useful in allele specific PCR.

Claims (23)

1. A method for the quantitation or detection of one or more target nucleic acid molecules in a sample during nucleic acid synthesis comprising:

mixing one or more a target nucleic acid molecules with one or more fluorescently labeled oligonucleotides, wherein said one or more oligonucleotides are labeled with only a single type of fluorescent label and said oligonucleotide undergoes a detectable change in fluorescence upon hybridization of said one or more oligonucleotides to said one or more target nucleic acid molecules;

incubating said mixture under conditions sufficient to synthesize one or more nucleic acid molecules complementary to all or a portion of said one or more target nucleic acid molecules, said one or more synthesized nucleic acid molecules comprising said one or more oligonucleotides; and

detecting the presence or absence or quantifying the amount of said one or more synthesized nucleic acid molecules by measuring said fluorescent label; wherein said fluorescent label is selected from the group consisting of JOE (2′7′-dimethoxy-4′5′-dichloro-6-carboxyfluorescein), FAM (5-carboxyfluorescein), TAMRA (N,N,N′,N′-tetramethyl-6-carboxyrhodamine), or ROX (6-carboxy-X-rhodamine).

2. A method for quantitation or detection of one or more target nucleic acid molecules in a sample during nucleic acid amplification comprising:

mixing one or more target nucleic acid molecules with one or more fluorescently labeled oligonucleotides under conditions sufficient to amplify one or more nucleic acid molecules complementary to all or a portion of said one or more target nucleic acid molecules, said one or more amplified nucleic acid molecules comprising said one or more oligonucleotides, wherein said one or more oligonucleotides are labeled with only a single type of fluorescent label and said oligonucleotide undergoes a detectable change in fluorescence upon hybridization of said one or more oligonucleotides to said one or more target nucleic acid molecules; and

detecting the presence or absence or quantifying the amount of said one or more target nucleic acid molecules by measuring said fluorescent label; wherein said fluorescent label is selected from the group consisting of (2′7′-dimethoxy-4′5′-dichloro-6-carboxyfluorescein), FAM (5-carboxyfluorescein), TAMRA (N,N,N′,N′-tetramethyl-6-carboxyrhodamine), or ROX (6-carboxy-X-rhodamine).

3. The method of claims 1 or 2 , wherein said detection step comprises detecting or measuring the level of activity of the fluorescent label during said synthesis or amplification compared to the level of activity of the fluorescent label in the absence of said synthesis or amplification.

4. The method of claim 2 , wherein said amplification is accomplished by at least one method selected from the group consisting of PCR, 5-RACE, RT PCR, Allele-specific PCR, Anchor PCR, “one-sided PCR,” LCR, NASBA, and SDA.

5. The method of any one of claims 1 or 2 , wherein said one or more oligonucleotides comprise one or more hairpin structures.

6. A method for amplifying a double stranded nucleic acid molecule, comprising:

providing a first and second primer, wherein said first primer is complementary to a sequence within or at or near the 3″-termini of the first strand of said nucleic acid molecule and said second primer is complementary to a sequence within or at or near the 3″-termini of the second strand of said nucleic acid molecule;

hybridizing said first primer to said first strand and said second primer to said second strand in the presence of one or more polymerases, under conditions such that said primers are extended to result in the synthesis of a third nucleic acid molecule complementary to all or a portion of said first strand and a fourth nucleic acid molecule complementary to all or a portion said second strand;

denaturing said first and third strands, and said second and fourth strands; and

repeating the above steps one or more times, wherein one or both of said first and second primers are labeled with only a single type of fluorescent label, wherein said fluorescent label is selected from the group consisting of (2′7′-dimethoxy-4′5′-dichloro-6-carboxyfluorescein), FAM (5-carboxyfluorescein), TAMRA (N N,N′,N′-tetramethyl-6-carboxyrhodamine), or ROX (6-carboxy-X-rhodamine);

and wherein said primer undergoes a detectable change in fluorescence upon hybridization of said one or more labeled primers to said nucleic acid molecule.

7. The method of claim 6 , wherein at least one of said primers comprises at least one hairpin structure.

8. The method of claim 6 , wherein said primers further comprise one or more hairpin structures.

9. The method of any one of claims 1 , 2 , or 6 , wherein said detectable label is at the fourth base from the 3′ termini.

10. The method of any one of claims 1 , 2 , or 6 , wherein said detectable label is at the fifth base from the 3′ termini.

11. The method of any one of claims 1 , 2 , or 6 , wherein said detectable label is at the sixth base from the 3′ termini.

12. The method of any one of claims 1 , 2 , or 6 , wherein said detectable label is attached to one of the ten 3′-most terminal nucleotides.

13. The method of any one of claims 1 , 2 , or 6 , wherein said detectable label is attached to one of the twenty 3′-most terminal nucleotides.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO 09452626 PREVIOUSLY RECORDED ON REEL 023882 FRAME 0551. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER SHOULD NOT HAVE BEEN RECORDED AGAINST THIS PATENT APPLICATION NUMBER. Recorded Nov 14, 2014
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 034217/0490 →
LIEN RELEASE Recorded Apr 9, 2013
From: BANK OF AMERICA, N.A.
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 030182/0461 →
MERGER Recorded Feb 3, 2010
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 023882/0551 →
CHANGE OF NAME Recorded Apr 13, 2009
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 022539/0235 →
SECURITY AGREEMENT Recorded Dec 5, 2008
From: LIFE TECHNOLOGIES CORPORATION
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 021975/0467 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2000
From: NAZARENKO, IRINA; RASHTCHIAN, AYOUB
To: INVITROGEN CORPORATION
Reel/Frame 011281/0860 →